Previous 10 | Next 10 |
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q1 2022 Earnings Call May 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q1 2022 Earnings Call Transcript
OPKO Health, Inc. (OPK) Q1 2022 Earnings Conference Call May 09, 2022, 16:30 ET Company Participants Yvonne Briggs - LHA Phillip Frost - Chairman & CEO Adam Logal - SVP, CFO, CAO & Treasurer Jon Cohen - SVP & Director Elias Zerhouni - Incoming President & Vice Chairman Confere...
OPKO Health press release (NASDAQ:OPK): Q1 GAAP EPS of -$0.08 misses by $0.02. Revenue of $329.2M (-39.6% Y/Y) misses by $2.25M. Cash and cash equivalents were $102.3 million as of March 31, 2022. Shares -5%. For further details see: OPKO Health GAAP EPS of -$0.08 misses by $0.02,...
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2022. Business Highlights Business highlights for the first quarter of 2022 and subsequent weeks include the follo...
Diagnostic firm OPKO Health (NASDAQ:OPK) said on Monday it was buying privately-held ModeX Therapeutics for $300 million in common stock to expand its portfolio to include cancer and infectious disease products. ModeX, which was founded in October 2020, product portfolio ...
Dr. Elias Zerhouni, ModeX Chairman, former President of Global R&D at Sanofi and former NIH Director, named President and Vice Chairman of OPKO Dr. Gary Nabel, ModeX President and CEO, former Chief Scientific Officer at Sanofi and founder of NIH’s Vaccine Research C...
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT, CAPL, CARA, CARG, CHMI, CLAR, CLOV, CNNE, CSTL, OTCPK:CURLF, DDD, DHT, DNB, ENTA, EQH, EVBG, FCRD, FF, FGEN, FLL, ...
MIAMI, May 05, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2022 after the close of the U.S. financial markets on Monday, May 9, 2022. OPKO’s senior management will provide a business...
OPKO Health has historically encountered many financial difficulties even as it continues to find support for its work. The global pandemic has allowed the company to revise how it conducts its business and could mark the start of a profitable new era. Demand for testing has decli...
Gainers: Burning Rock Biotech Limited (BNR) +5%. Hemisphere Media Group (HMTV) +4%. Neuronetics (STIM) +4%. AvePoint (AVPT) +3%. Jounce Therapeutics (JNCE) +3%. Losers: UroGen Pharma (URGN) -12%. Purple Innovation (PRPL) -5%. Trinity Capital (TRIN) -4%. ...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...